Finance

Lists
500420:BOM
Torrent Pharmaceuticals Ltd
₹ 4,560.00
-1.00%
(-45.95) 1D
10-р сарын 16, 15:57:43 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500420...
Open
₹ 4,579.80
High
₹ 4,619.10
Low
₹ 4,554.00
Mkt. cap
1.54ИН
Avg. vol.
9.70 мян
Volume
2.90 мян
Dividend
0.83%
Quarterly dividend
₹ 9.50
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
72.84
52-wk high
₹ 5,249.95
52-wk low
₹ 3,511.00
EPS
₹ 62.60
Shares outstanding
170.00 сая
No. of employees
18 мян
Open
₹ 4,579.80
High
₹ 4,619.10
Low
₹ 4,554.00
Mkt. cap
1.54ИН
Avg. vol.
9.70 мян
Volume
2.90 мян
Dividend
0.83%
Quarterly dividend
₹ 9.50
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
72.84
52-wk high
₹ 5,249.95
52-wk low
₹ 3,511.00
EPS
₹ 62.60
Shares outstanding
170.00 сая
No. of employees
18 мян
News stories
From web sources and news partners
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees18.3 мян
Founded1959
HeadquartersАхмадабад, Гужарат, Энэтхэг
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
33.02 тэрбум
33.03 тэрбум
41.97 тэрбум
49.21 тэрбум
Cost of goods sold
8.00 тэрбум
7.99 тэрбум
10.15 тэрбум
11.63 тэрбум
Cost of revenue
8.00 тэрбум
7.99 тэрбум
10.15 тэрбум
11.63 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.27 тэрбум
6.51 тэрбум
8.48 тэрбум
8.93 тэрбум
Operating expense
16.23 тэрбум
16.22 тэрбум
23.34 тэрбум
26.87 тэрбум
Total operating expenses
24.23 тэрбум
24.21 тэрбум
33.49 тэрбум
38.50 тэрбум
Operating income
8.79 тэрбум
8.82 тэрбум
8.48 тэрбум
10.71 тэрбум
Other non operating income
-270.00 сая
-130.00 сая
794.40 сая
-120.00 сая
EBT including unusual items
7.91 тэрбум
8.14 тэрбум
5.29 тэрбум
7.33 тэрбум
EBT excluding unusual items
8.04 тэрбум
8.24 тэрбум
5.47 тэрбум
7.54 тэрбум
Income tax expense
2.00 тэрбум
1.79 тэрбум
1.65 тэрбум
1.67 тэрбум
Effective tax rate
25.28%
21.99%
31.18%
22.78%
Other operating expenses
7.92 тэрбум
7.65 тэрбум
9.78 тэрбум
12.01 тэрбум
Net income
5.91 тэрбум
6.35 тэрбум
3.89 тэрбум
5.66 тэрбум
Net profit margin
17.90%
19.22%
9.28%
11.50%
Earnings per share
17.75
19.00
12.85
15.30
Interest and investment income
-
-
384.30 сая
-
Interest expense
-480.00 сая
-450.00 сая
-2.36 тэрбум
-3.05 тэрбум
Net interest expenses
-480.00 сая
-450.00 сая
-1.97 тэрбум
-3.05 тэрбум
Depreciation and amortization charges
2.04 тэрбум
2.06 тэрбум
5.08 тэрбум
5.93 тэрбум
EBITDA
10.82 тэрбум
10.69 тэрбум
11.12 тэрбум
13.35 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс